Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-01 5:55 pm Purchase |
2025-06-24 | 13G | Enzo Biochem, Inc. ENZB |
Beryl Capital Management LLC | 5,069,789 9.700% |
5,069,789 (New Position) |
Filing History |
| 2025-06-30 4:15 pm Purchase |
2025-06-23 | 13D | Enzo Biochem, Inc. ENZB |
Battery Ventures XIV, L.P. | 11,575,824 21.800% |
11,575,824 (New Position) |
Filing History |
| 2025-06-25 6:00 pm Unchanged |
2025-06-23 | 13D | Enzo Biochem, Inc. ENZB |
Harbert Discovery Fund, LP | 5,175,913 9.870% |
0 (Unchanged) |
Filing History |
| 2025-06-25 4:33 pm Purchase |
2025-06-23 | 13D | Enzo Biochem, Inc. ENZB |
Radoff Bradley Louis | 4,820,882 9.200% |
215,750 (+4.68%) |
Filing History |
| 2024-02-14 10:23 am Sale |
2023-12-31 | 13G | Enzo Biochem, Inc. ENZB |
1 MAIN CAPITAL MANAGEMENT LLC | 2,500,000 4.950% |
-374,125 (-13.02%) |
Filing History |
| 2024-02-13 09:35 am Sale |
2023-12-29 | 13G | Enzo Biochem, Inc. ENZB |
RENAISSANCE TECHNOLOGIES LLC | 2,479,195 4.910% |
-334,769 (-11.90%) |
Filing History |
| 2023-09-11 5:14 pm Purchase |
2023-09-01 | 13G | Enzo Biochem, Inc. ENZB |
1 MAIN CAPITAL MANAGEMENT LLC | 2,874,125 5.800% |
2,874,125 (New Position) |
Filing History |
| 2023-07-24 4:20 pm Sale |
2023-07-24 | 13D | Enzo Biochem, Inc. ENZB |
LABCORP HOLDINGS INC. LH |
0 0.000% |
-4,862,730 (Position Closed) |
Filing History |
| 2023-05-10 5:19 pm Purchase |
2023-03-16 | 13D | Enzo Biochem, Inc. ENZB |
Radoff Bradley Louis | 4,605,132 9.300% |
307,032 (+7.14%) |
Filing History |
| 2023-03-27 4:32 pm Purchase |
2023-03-16 | 13D | Enzo Biochem, Inc. ENZB |
LABCORP HOLDINGS INC. LH |
4,862,730 9.800% |
4,862,730 (New Position) |
Filing History |
| 2023-02-13 10:10 am Sale |
2022-12-30 | 13G | Enzo Biochem, Inc. ENZB |
RENAISSANCE TECHNOLOGIES LLC | 2,813,964 5.780% |
-280,800 (-9.07%) |
Filing History |
| 2023-01-23 1:23 pm Purchase |
2022-11-23 | 13D | Enzo Biochem, Inc. ENZB |
James G. Wolf | 4,942,400 10.140% |
773,900 (+18.57%) |
Filing History |
| 2022-11-23 11:33 am Purchase |
2022-11-23 | 13D | Enzo Biochem, Inc. ENZB |
James G. Wolf | 4,168,500 8.560% |
54,000 (+1.31%) |
Filing History |
| 2022-10-26 1:07 pm Purchase |
2022-10-18 | 13D | Enzo Biochem, Inc. ENZB |
James G. Wolf | 4,114,500 8.450% |
852,000 (+26.11%) |
Filing History |
| 2022-03-24 5:50 pm Sale |
2022-03-21 | 13D | Enzo Biochem, Inc. ENZB |
Roumell Asset Management LLC | 2,426,771 4.980% |
-460,000 (-15.93%) |
Filing History |
| 2022-02-14 10:49 am Sale |
2021-12-31 | 13G | Enzo Biochem, Inc. ENZB |
RENAISSANCE TECHNOLOGIES LLC | 3,094,764 6.380% |
-461,459 (-12.98%) |
Filing History |
| 2022-02-10 08:11 am Sale |
2021-12-31 | 13G | Enzo Biochem, Inc. ENZB |
The Vanguard Group | 1,783,048 3.680% |
-614,750 (-25.64%) |
Filing History |
| 2022-01-18 10:56 am Sale |
2021-12-31 | 13G | Enzo Biochem, Inc. ENZB |
Evermore Global Advisors LLC | 0 0.000% |
-2,605,607 (Position Closed) |
Filing History |
| 2022-01-04 11:10 am Unchanged |
2022-01-03 | 13D | Enzo Biochem, Inc. ENZB |
Radoff Bradley Louis | 4,298,100 8.900% |
0 (Unchanged) |
Filing History |
| 2021-12-27 4:38 pm Purchase |
2021-12-03 | 13D | Enzo Biochem, Inc. ENZB |
Radoff Bradley Louis | 4,298,100 8.900% |
683,100 (+18.90%) |
Filing History |